Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3392348 | 0.86 | MGAM (0.41) | KMT2AMAPT | |
| SCHEMBL3392227 | 0.86 | MGAM (0.41) | KMT2AMAPT | |
| SCHEMBL7505999 | 0.84 | ZDHHC7 (0.44) | ZDHHC7GPR84KMT2AFFAR1CPB2 | |
| SCHEMBL7509050 | 0.84 | ZDHHC7 (0.44) | ZDHHC7GPR84KMT2AFFAR1CPB2 | |
| SCHEMBL7204081 | 0.84 | ZDHHC7 (0.49) | ZDHHC7GPR84KMT2AFFAR1CPB2 | |
| SCHEMBL7512070 | 0.84 | ZDHHC7 (0.44) | ZDHHC7GPR84KMT2AFFAR1CPB2 | |
| SCHEMBL7779110 | 0.84 | ZDHHC7 (0.49) | ZDHHC7GPR84KMT2AFFAR1CPB2 | |
| SCHEMBL7509191 | 0.84 | ZDHHC7 (0.43) | ZDHHC7GPR84KMT2AFFAR1CPB2 | |
| SCHEMBL6829979 | 0.82 | ZDHHC7 (0.42) | ZDHHC7GPR84KMT2AFFAR1CPB2 | |
| SCHEMBL1479671 | 0.81 | ZDHHC7 (0.39) | ZDHHC7GPR84NAAADGKAFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130053433-A1 | FATTY ACID DERIVATIVES AND ANALOGS OF DRUGS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053433-A1 | FATTY ACID DERIVATIVES AND ANALOGS OF DRUGS | FFAR2, FASN, FFAR4 | ZDHHC7 236/4885GPR84 613/4885KMT2A 3473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.